NCT02715908View on ClinicalTrials.gov

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

PHASE3CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions

Rheumatoid Arthritis

Interventions

DRUG

LBEC0101

Etanercept 50mg

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT02715908 - A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) | Biotech Hunter | Biotech Hunter